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PQUARTERLY FOCUS ISSUE: HEART RHYTHM DISORDERS
Transient Local Injury Current
in Right Ventricular Electrogram After
Implantable Cardioverter-Defibrillator
Shock Predicts Heart Failure Progression
Larisa G. Tereshchenko, MD, PHD,*† Mitchell N. Faddis, MD, PHD,† Barry J. Fetics, MS,*
Karl E. Zelik, MS,‡§ Igor R. Efimov, PHD,‡ Ronald D. Berger, MD, PHD*
Baltimore, Maryland; St. Louis, Missouri; and Ann Arbor, Michigan
Objectives This study aimed to identify an early marker of functional impairment after an implantable cardioverter-
defibrillator (ICD) shock as a predictor of heart failure progression.
Background The ICD population has substantial risk of death due to progressive pump failure.
Methods Near-field (NF) bipolar right ventricular (RV) electrograms (EGMs) during induced ventricular fibrillation (VF) and
10 s after rescue ICD shock were analyzed in 310 patients (mean age 59  14.5 years, 219 men [71%]) with
structural heart disease, New York Heart Association functional class I to III, and implanted with a single- or
dual-chamber Medtronic (Minneapolis, Minnesota) ICD for primary (245 patients, 79%) or secondary prevention
of sudden cardiac arrest. A local injury current (LIC) on NF RV EGM was defined as a deviation of EGM potential
1 mV or 15% of the preceding R-wave peak-to-peak amplitude.
Results During mean follow-up of 29.3  15.0 months, the combined end point of death or hospitalization due to con-
gestive heart failure (CHF) exacerbation was documented in 40 patients (12.9%, or 5.3% per person-year of
follow-up). LIC was observed in 106 patients. In multivariate risk analysis, after adjustment for baseline prognos-
tic factors (ejection fraction, history of atrial fibrillation, diabetes mellitus) and appropriate ICD shocks during
follow-up, patients with observed LIC after induced VF rescue ICD shock at ICD implantation were more likely to
die or to be hospitalized (hazard ratio: 2.69; 95% confidence interval: 1.41 to 5.14; p  0.003).
Conclusions Transient LIC on bipolar NF RV EGM after induced VF rescue ICD shock is associated with increased risk of CHF
progression, future hospitalizations due to CHF exacerbation, and subsequent heart failure death. (J Am Coll
Cardiol 2009;54:822–8) © 2009 by the American College of Cardiology Foundation











dmplantable cardioverter-defibrillators (ICDs) improve sur-
ival of patients who are at risk for sudden cardiac arrest
SCA) (1–4). However, long-term follow-up of ICD pa-
ients with congestive heart failure (CHF) has shown that
oth appropriate (5–7) and inappropriate (5,8) ICD shocks
re associated with increased risk of death, predominantly
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ccepted June 11, 2009.rom progressive heart failure. Thoughtful medical manage-
ent of heart failure and programming of ICD therapies in
his patient cohort might improve the prognosis, but no
arly markers of heart failure progression available at the
ime of ICD implantation are known.
See page 829
Extensive data indicate that defibrillation shocks are
ccompanied by transient adverse effects. These adverse
ffects include: 1) transient ectopy, tachycardia, or induction
f ventricular fibrillation (VF) (9,10); 2) complete heart
lock and increased pacing thresholds (10,11); 3) atrial and
entricular mechanical dysfunction (stunning) (12–15); 4)
ignificant elevation of troponin I serum level (16); and 5)
ecrease of the myocardial lactate extraction rate by mito-
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August 25, 2009:822–8 Post-ICD Shock Injury Currentfter an ICD shock could predict future progression of
HF remains unclear.
Changes of electrocardiogram (ECG) and intracardiac
lectrograms (EGMs) during ICD implantation procedures
ere observed previously. Transient ST-segment elevation
n surface ECG after induced VF rescue ICD shock was
escribed in 19% of patients (18), but its prognostic signif-
cance was not studied. Other investigators have shown that
current of injury on intracardiac EGM within 10 min of
ead fixation serves as a marker of adequate active lead
xation during an ICD or pacemaker implantation proce-
ure (19,20). The prognostic significance of transient local
njury current (LIC) on near-field (NF) right ventricular
RV) EGM after induced VF rescue ICD shock is un-
nown. We hypothesized that LIC on bipolar NF RV
GM after induced VF rescue ICD shock predicts future
HF progression in patients with New York Heart Asso-
iation (NYHA) functional class I to III CHF.
ethods
he study protocol was approved by the Johns Hopkins
niversity and the Washington University Human Studies
ommittees, and all patients gave written informed consent
efore entering the study.
tudy population. This is prospective observational study.
ale and female patients older than 18 years with structural
eart disease and NYHA functional class I to III CHF were
ligible for the study if they had a Medtronic (Minneapolis,
innesota) transvenous single- or dual-chamber ICD de-
ice with dedicated bipolar ICD lead implanted for primary
r secondary prevention of SCA within 1 week before
nrollment. Exclusion criteria were indications for cardiac
esynchronization therapy defibrillator and NYHA func-
ional class IV, contraindications for defibrillation threshold
esting (DFT), pregnancy, inherited channelopathies, and
oncomitant conditions other than cardiac diseases that
ere associated with a high likelihood of death during 1 year
fter enrollment.
Ventricular tachycardia (VT)/VF was induced with a
hock-on T-wave protocol. Stored intracardiac EGMs re-
orded during DFT (induced tachyarrhythmia and 10 s
ost-ICD shock) were extracted from the ICD memory 7
ays after procedure, converted into digital format using
roprietary Medtronic software, and further analyzed using
ustom Matlab (The MathWorks, Inc., Natick, Massachu-
etts) software application. Control recordings of NF RV
GM at rest simultaneously with 1-lead (lead II) surface
CG were obtained via Medtronic programmer 2090 using
he NI USB-9215A portable data acquisition system (Na-
ional Instruments, Austin, Texas) 7 days after the procedure.
Programming of the ICD device was based on the attending
lectrophysiologist’s clinical evaluation. Patients were
ollowed-up in the Washington University Arrhythmia Clinic
nd via the Internet-based CareLink (Medtronic, Inc., Min-eapolis, Minnesota) remote
onitoring system. All ICD inter-
ogation data were adjudicated by
n ICD end point committee (at-
ending electrophysiologist and 2
f the investigators [L.G.T. and
.D.B.]). ICD shocks occurring
or VT or VF were classified as
ppropriate.
easurement of LIC on the bi-
olar NF RV EGM after in-
uced VF rescue ICD shock.
ndocardial NF RV EGM was
ecorded as the difference of po-
entials between the tip and the
ing of the dedicated bipolar
CD lead implanted in the RV
pex. The LIC was characterized
s the magnitude of elevated or
epressed potential immediately
fter the major fast EGM deflec-
ion (Fig. 1), measured from the
aseline (the isoelectric portion
efore the major EGM deflec-
ion) to its highest point in mil-
ivolts. Peak-to-peak amplitude
f major fast EGM deflection (R-wave) was measured to
ssess relative LIC on average representative beat. Signifi-
ant LIC was defined as a deviation of EGM potential 1
V or15% of preceding R-wave peak-to-peak amplitude.
igital EGM (bandpass filter 2 to 100 Hz) was magnified
nd measured after separate calibration of each recording (1
V equal to 30 to 40 pixels, Screen Calipers 4.0, Iconico,
nc., New York, New York). The first 2 s after shock were
xcluded. LIC was measured on every sinus beat and
veraged. Ventricular-paced beats, distorted beats of unde-
ermined origin, and ectopic beats were excluded.
Figure 1 Measurement of LIC
After Induced VF Rescue ICD Shock
ICD  implantable cardioverter-defibrillator; LIC  local injury
current; R  peak-to-peak R-wave amplitude; VF  ventricular fibrillation.
Abbreviations
and Acronyms
CHF  congestive heart
failure




HR  hazard ratio
ICD  implantable
cardioverter-defibrillator
LIC  local injury current
LVEF  left ventricular
ejection fraction
NF  near field
NYHA  New York Heart
Association
RV  right ventricle/
ventricular
SCA  sudden cardiac
arrest
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Post-ICD Shock Injury Current August 25, 2009:822–8nd points. Either of 2 major CHF events—death or
ospitalization due to CHF exacerbation, whichever came
rst—served as the primary end point. We use the term
CHF event” to refer to this combined end point through-
ut the report. Cases of death with clear confirmed noncar-
iovascular cause were censored at the time of the last office
isit. Time to event was measured from the day of ICD
mplantation.
tatistical analysis. Results are presented as mean  SD
or normally distributed variables, and as median and
nterquartile range for skewed distributions. Continuous
ariables were compared using the independent samples t
est if normally distributed and the Wilcoxon rank sum test
f skewed. The Pearson chi-square test was used to compare
ategorical variables. A p value of 0.05 was considered
ignificant. Kaplan-Meier survival analysis was used to
ompute mean and median survival time. The log-rank
Mantel-Cox) statistic was computed to test the equality of
urvival distributions. Cox multivariate regression model
as used for adjustment by known predictors of CHF
rogression. Appropriate ICD shock for VT/VF at follow-up
as treated as a time-dependent covariate. SPSS version
7.0.0 (SPSS Inc., Chicago, Illinois) and STATA version
0 (StataCorp LP, College Station, Texas) software pack-





(n  204) p Value
Age, yrs 59.9 11.7 61.5 14.9 0.534
Men 74 (69.8) 145 (79.9) 0.816
African Americans 20 (18.8) 28 (15.9) 0.422
Ischemic CM with MI history 72 (68.8) 115 (64.6) 0.389
Primary prevention of SCD 82 (77.4) 163 (79.9) 0.602
Single-chamber ICD 83 (78.3) 92 (45.1) 0.0001
LVEF at ICD implantation, % 33.4 11.6 32.8 12.2 0.797
NYHA functional class I 19 (18.4) 54 (26.3) 0.699
NYHA functional class III 20 (18.8) 35 (19.5) 0.946
Diabetes mellitus 46 (43.8) 62 (34.6) 0.197
Hypertension 89 (85.4) 119 (67.1) 0.016
CABG 37 (35.4) 62 (34.6) 0.535
PTCA 37 (35.4) 53 (29.6) 0.312
Beta-blockers 87 (83.3) 160 (90.1) 0.195
Digoxin 41 (38.4) 56 (27.6) 0.046
Aldosterone antagonists 50 (47.2) 53 (26.1) 0.0001
Nitrates 21 (19.8) 42 (20.7) 0.856
Class III antiarrhythmics 85 (80.2) 154 (75.5) 0.350
VT/VF with appropriate ICD shocks 29 (27.4) 49 (24.0) 0.465
Renal failure 13 (12.5) 41 (23.2) 0.102
History of atrial fibrillation 24 (22.6) 48 (23.5) 0.633
alues are mean  SD or n (%).
CABG coronary artery bypass grafting; CM cardiomyopathy; ICD implantable cardioverter-
efibrillator; LIC  local injury current; LVEF  left ventricular ejection fraction; MI  myocardial
nfarction; NYHA  New York Heart Association; PTCA  percutaneous transluminal coronary
ngioplasty; SCD  sudden cardiac death; VF  ventricular fibrillation; VT  ventricular
achycardia.ges were used for calculations. Aesults
tudy population. The study population consisted of 310
atients (mean age 59.0  14.5 years, 219 [71%] men) who
nderwent ICD implantation for primary (n  245, 79%)
r secondary (n  65, 21%) prevention of SCA. Ischemic
ardiomyopathy with myocardial infarction history was
iagnosed in 187 (60.3%) patients and nonischemic cardio-
yopathy in 123 (39.7%) patients. A single-chamber ICD
as implanted in 175 (56.5%) patients, and dual-chamber
CD in 135 (43.5%) patients. A new dedicated bipolar
ransvenous ICD lead was implanted in 264 (85.1%) pa-
ients, and an ICD generator change procedure was per-
ormed in 46 (14.9%) patients who had had an ICD lead
mplanted more than 1 year ago. Only the first induced
T/VF and EGM after the first rescue ICD shock was
nalyzed.
ipolar NF RV EGM changes after induced VF rescue
CD shock. Significant LIC after induced rescue ICD
hock was found in 106 (34.2%) patients. The baseline
haracteristics of the patients are summarized in Table 1,
nd ICD shock characteristics are summarized in Table 2.
igure 2 shows examples of EGM changes after induced VF
escue ICD shock. Control EGMs obtained 7 days after the
rocedure confirmed that observed changes were temporary
nd demonstrated isoelectric potential.
eath, CHF hospitalizations, and appropriate ICD
hocks. During a mean follow-up of 29.3  15.0 months,
he combined end point of death or hospitalization due to
HF exacerbation was documented in 40 patients (12.9%,
r 5.3% per person-year of follow-up). Appropriate ICD
hocks were observed in 78 patients (25.2%, or 10.3% per
erson-year of follow-up); of these patients, 3 patients died
edian 113 days after appropriate ICD shocks, and 3
atients underwent successful heart transplantation. CHF
vents were twice as frequent among patients with appro-
riate ICD shocks (n  16, 20.5%) compared with patients
ithout sustained arrhythmia (n  24 of 232, 10.3%; p 
.020). ICD shock preceded CHF event by median 132
ays (interquartile range 6 to 627 days).
isk of CHF progression associated with LIC at ICD
mplantation. LIC () patients had a higher CHF event-
ree survival rate during follow-up (88.1% vs. 71.1%, p 
.015) (Fig. 3A). Cox proportional hazard ratio (HR) for
he newly implanted ICD lead subgroup was higher (HR:
.29, 95% confidence interval [CI]: 1.54 to 7.06, p 0.002)
han for all patients (HR: 2.61, 95% CI: 1.37 to 4.99, p 





(n  204) p Value
Cycle length of induced VF, ms 199.5 26.8 208.6 29.8 0.031
Duration of induced VF event, s 9.7 3.5 9.3 2.3 0.309
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August 25, 2009:822–8 Post-ICD Shock Injury Current.004). Figure 3B shows Kaplan-Meier curves when the
nalysis was confined to patients with newly implanted
eads. This effect was not significant for the chronic ICD
ead subgroup (HR: 0.78, 95% CI: 0.09 to 6.67, p 0.820).
ultivariate Cox model that included LIC, time-dependent
ppropriate ICD shocks at follow-up, new/chronic lead
actor, and interaction between LIC and the lead factor
onfirmed effect modification (p  0.0001).
In patients with LIC, subsequent sustained VT/VF
vents with appropriate ICD shocks predicted CHF pro-
ression (Fig. 4A) (event-free survival 40% vs. 80%, p 
.006), whereas in patients without LIC, subsequent
Figure 2 RV EGMs: Control and After ICD Shock
(A) Typical post-shock implantable cardioverter-defibrillator (ICD) recording of
right ventricular (RV) near-field electrogram (EGM) in control recording, and after
ICD shock in patients with local injury current (A), and in patients with lack of
injury (B).T/VF was not predictive (Fig. 4B) (event-free survival7% vs. 88%, p  0.683). Multivariate Cox regression
odel that included LIC, time-dependent appropriate ICD
hocks, and interaction between LIC and ICD shocks
onfirmed significant effect modification (p  0.001).
After adjustment for baseline factors (age, race, left
entricular ejection fraction [LVEF], NYHA functional
lass, history of diabetes mellitus, atrial fibrillation or flutter,
enal failure, hypertension, use of digoxin and aldosterone
ntagonists) and time-dependent appropriate ICD shocks
uring follow-up, LIC signified a highly increased risk of
ubsequent CHF events. Each Cox model included LIC,
ime-dependent appropriate ICD shocks during follow-up,
YHA functional class, and other covariates tested one by
ne as listed in Table 3. LIC was a significant predictor in
Figure 3 LIC Predicts Risk of CHF
Kaplan-Meier curves for freedom from congestive heart failure (CHF) events in
patients with significant local injury current (LIC) () and those with the LIC ()
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Post-ICD Shock Injury Current August 25, 2009:822–8ll tested Cox models with HR from 2.2 to 2.6 (p  0.01).
Rs of time-dependent appropriate ICD shock at
ollow-up ranged from 2.5 to 7.1. Time-dependent appro-
riate ICD shock at follow-up was not a significant predic-
or in the models that included cycle length of VF and renal
ailure. NYHA functional class HRs ranged from 2.7 to 3.1
Figure 4 LIC Modifies CHF Risk After ICD Shock
Kaplan-Meier curves for freedom from CHF events in patients with and without
appropriate ICD shocks at follow-up among LIC () patients (A), and LIC ()
patients (B). Abbreviations as in Figures 1 and 2.nd were significant in all models (p  0.001). iiscussion
o our knowledge, this is the first description of LIC on
ipolar NF RV EGM after ICD shock. Our results demon-
trate for the first time that transient myocardial injury after
nduced VF rescue ICD shock manifesting as LIC on bipolar
F RV EGM is associated with increased risk of CHF
rogression, future hospitalizations due to CHF exacerbation,
nd heart pump failure death. LIC after induced VF rescue
CD shock was a predictor of adverse CHF outcomes after
djustment by traditional risk factors, including appropriate
CD shocks and LVEF or NYHA functional class, and
rovided additional prognostic information.
We propose a “triple-hit” hypothesis to explain the
enesis of LIC on the NF RV EGM: 1) cardiac myocytes
re fragile due to an underlying condition that leads to
rogressive CHF; 2) mechanical injury occurs due to lead
lacement; and 3) a rescue ICD shock elicits LIC, especially
f the first 2 “hits” are present.
HF progression in ICD patients. High risk of death
ue to pump failure in ICD patient populations without or
fter appropriate ICD therapies remains an important
ealth care problem. Several clinical factors elucidated to be
rognostic for CHF progression in ICD patients in previous
tudies are appropriate and inappropriate ICD shocks (5),
enal failure (21), NYHA functional class, and LVEF (22).
ur study is the first to show that the LIC phenomenon
fter induced VF rescue ICD shock carries an independent
igh risk, if observed in newly implanted ICD leads.
It is known that neurohumoral and cytokine activations
ontribute to the inflammatory and oxidative characteristics
f CHF patients (23). We speculate that these pathways
hat have been activated for the long term in at-risk CHF
atients result in a dramatic response to induced VF rescue
CD shock. Since patients without subsequent CHF were less
ikely to exhibit LIC, susceptibility for heart failure progression
ppears to be the “first hit” prerequisite for the LIC phenom-
non we observed, and allows the appearance of LIC to serve
s a marker of CHF risk.
ocal mechanical myocardial injury and injury current on
ipolar intracardiac EGM. Transient LIC presenting on
F RV EGM during the acute placement of an ICD or
acemaker lead is well known. Several groups of investiga-
ors linked characteristics of LIC at the time of an active-
xation lead placement with subsequent adequate lead
xation (19,20) and with lead perforation (24). Transvenous
nsertion of endocardial leads for permanent pacing (25) or
se with an ICD (26) is accompanied by acute injury,
ollowed by a sequence of cardiac histopathological changes
tarting with acute inflammation and leading eventually to
he formation of a fibrous connective tissue scar (27,28).
aximum ventricular lead diameter, number of implanted
eads (25), and CRT device left ventricular lead placement
29) were independent predictors of peak cardiac troponin I
evels in patients undergoing conventional pacemaker/ICD
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August 25, 2009:822–8 Post-ICD Shock Injury Currenthronic leads is a finding that suggests recent local mechan-
cal injury is usually required as the “second hit” for LIC to
ccur. Future study is needed to determine the optimal
rognostic time window from lead fixation to VT/VF
nduction.
ransient myocardial injury after ICD shock. According
o the excitation theory of defibrillation, electrical shocks
epolarize the membranes of most cardiac cells, resulting in
esynchronization of electrical activity of the heart. If
hock-induced changes in transmembrane potential are
xcessively large, they can cause transient cell membrane
amage due to electroporation (30–32). Other potential
auses of myocardial injury after an ICD shock include free
adical formation (33,34) and conformation changes of the
embrane ion channels (35). We speculate that enhanced
IC on bipolar NF RV EGM after an ICD shock in
atients prone to subsequent CHF progression is produced
y local voltage gradients, resulting from potential differ-
nces between electroporated myocardial cells and normal
ells. In our study, LIC was observed after ICD shock, but
ot in subsequent control EGMs, thus supporting the
mportance of the shock and possibly the induced arrhyth-
ia) for the “third hit.”
Our results show that appropriate ICD shock predicts
uture CHF exacerbation and death only in patients with
ignificant LIC after rescue ICD shock. Conversely, pa-
ients without LIC and subsequent appropriate ICD shocks
uring follow-up had the same favorable course as patients
ithout ICD shocks. This important clinical finding sug-
ests that ICD shock does not cause, but rather unveils, risk
f progressive CHF.
tudy limitations. Our observations were limited by the
0-s post-shock EGM recording storage. We were unable
o determine a final recovery time point and duration of
GM changes. EGM after ICD lead fixation but before
Univariate and Multivariate HRs of Tested PrediTable 3 Univariate and Multivariate HRs of
Predictor Unadjuste
LIC 2.61 (1.3
NYHA functional class 2.69 (1.9
Time-dependent appropriate ICD shocks 2.67 (1.4
LVEF 0.95 (0.9
Diabetes mellitus 1.73 (1.0
Single-chamber ICD device 0.65 (0.4
History of hypertension 1.92 (1.0
Digitalis 2.02 (1.2
Aldosterone antagonists 2.02 (1.2
Cycle length of induced VF 1.00 (0.9
Atrial fibrillation 3.15 (1.6
African-American race 3.00 (1.8
Renal failure 2.68 (1.3
Age 1.00 (0.9
Each multivariate test includes LIC, time-dependent appropriate ICD s
one. Ejection fraction was tested in the model without NYHA functiona
relative risk of the death or hospitalization due to congestive heart fa
CI  confidence interval; other abbreviations as in Table 1.nduced VT/VF was not available for analysis.
lSpecific filter settings on bipolar NF RV EGM may
reclude analysis of other manufacturers’ EGMs. The small
umber of end point events limited multivariate Cox regres-
ion analysis.
The small number of chronic leads in this study prompts
urther investigation of LIC after ICD shock in chronic
eads to determine its predictive value for subsequent CHF
xacerbation.
In this study, we did not test the effect of ICD shock
lone, without preceding induced arrhythmia, on the gen-
sis of LIC. Theoretically, this could have been assessed at
evice implantation through the use of a protocol for upper
imit of vulnerability testing (36,37), instead of that used to
etermine DFT.
onclusions
he observed LIC phenomenon predicts progression of
HF in ICD patients with appropriate ICD shocks, and
ith otherwise stable NYHA functional class I to III CHF.
arly awareness of the high risk of CHF exacerbation and
houghtful medical management may improve CHF prog-
osis in ICD patients.
cknowledgments
he authors thank Jane Chen, Timothy Smith, Marye
leva, and Bruce Lindsay for providing medical care for
tudy participants, and Judy Osborn for help with collection
f follow-up data.
eprint requests and correspondence: Dr. Larisa G. Teresh-
henko, Carnegie 592, 600 North Wolfe Street, Baltimore, Mary-
d Predictors
95% CI), p Value Adjusted HR (95% CI), p Value
9), p 0.004 2.50 (1.31–4.79), p 0.005
3), p 0.0001 2.99 (1.45–6.15), p 0.003
5), p 0.003 6.71 (1.52–29.64), p 0.012
7), p 0.0001 0.94 (0.90–0.97), p 0.0001
2), p 0.019 1.50 (0.78–1.58), p 0.221
5), p 0.077 0.73 (0.34–1.58), p 0.423
5), p 0.045 2.10 (0.81–5.43), p 0.126
8), p 0.003 1.47 (0.76–2.83), p 0.252
8), p 0.003 1.70 (0.87–3.34), p 0.122
1), p 0.755 1.00 (0.99–1.02), p 0.741
1), p 0.0001 2.39 (0.90–6.34), p 0.080
4), p 0.0001 1.91 (0.93–3.89), p 0.077
7), p 0.005 2.08 (0.80–5.44), p 0.134
2), p 0.476 1.00 (0.97–1.02), p 0.725
NYHA functional class, and then other covariates were tested one by
Hazard ratio (HR) of appropriate ICD shock at follow-up indicates the
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